Vestiq Pharmaceuticals Offers MagBID ER Magnesium Dietary Supplement for Patients Who Have Lost Magnesium Because of Illness or Treatment With Certain Medicines MORRISVILLE, NC--(Marketwired - Jun 5, 2013) -  Vestiq Pharmaceuticals, Inc. today announced that it will add MagBID ER (magnesium L-lactate dehydrate) tablets to its growing list of supportive...

Vestiq Pharmaceuticals Enters Into Exclusive Distribution Agreement With BMG Pharma S.r.l. for GelX(R)* Oral Gel Treatment of Oral Mucositis MORRISVILLE, NC--(Marketwire - Feb 5, 2013) - Vestiq Pharmaceuticals, Inc. today announced that it has taken the rights for distribution of GelX Oral Gel from BMG Pharma S.r.l. GelX is an oral...

Vestiq Pharmaceuticals, Inc. Launches With Agenda for Rapid Growth, Acquires NDAs for ORAVIG(R) (Miconazole Buccal Tablets) and Zuplenz(R) (Ondansetron) Oral Soluble Film MORRISVILLE, NC--(Marketwire - Jan 16, 2013) - Vestiq Pharmaceuticals, an emerging Specialty Pharmaceutical Company, formally announces its launch of products that began commercialization in...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corp. NEW YORK, NY--(Marketwire - January 25, 2010) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on CEL-SCI Corp. (NYSE Amex:...